n-acetylmannosamine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, M; Clarke, A; Dharmarha, V; Douville, C; Galizzi, M; Gowda, P; Moremen, KW; Nairn, AV; Park, M; Saeui, CT; Shah, SR; Yarema, KJ | 1 |
| Aich, U; Campbell, CT; Choi, SS; Maisel, K; Sampathkumar, SG; Wang, JJ; Weier, CA; Wen, MM; Yarema, KJ | 1 |
2 other study(ies) available for n-acetylmannosamine and Breast Neoplasms
| Article | Year |
|---|---|
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycosylation; Hexosamines; Humans; N-Acetylneuraminic Acid; Tumor Cells, Cultured | 2018 |
Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Epigenesis, Genetic; Fatty Acids; Hexosamines; Humans; Matrix Metalloproteinase 9; Models, Biological; Neoplasm Metastasis; NF-kappa B; Receptors, CXCR4 | 2008 |